Stay updated on Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page.

Latest updates to the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAccess to the study record has been replaced by a 403 Forbidden page, effectively hiding the study details and related navigation. The change represents a site-level access issue that prevents users from viewing the trial information on this page.SummaryDifference18%

- Check23 days agoChange DetectedAdded Tel Litwinsky, Ramat - GAN, Israel, 5265601 to the list of study sites. Removed Qiryat Krinitzi, Ramat - GAN, Israel, 5265601 from the list of study sites.SummaryDifference0.0%

- Check30 days agoChange DetectedTel Litwinsky, Ramat - GAN, Israel, 5265601 was removed from the study locations. Qiryat Krinitzi, Ramat - GAN, Israel, 5265601 was added to the study locations.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page now lists NIH funding information for 2015. The revision note shows the page updated to version 3.6.6, replacing 3.6.5.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page footer now shows Revision: v3.6.5, replacing Revision: v3.6.4. This appears to be a platform update with no changes to the study details or the information presented to users.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision: v3.6.4 replaces v3.6.3 to reflect a minor update to the page's documentation and metadata.SummaryDifference0.0%

Stay in the know with updates to Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page.